The radial artery is the default access for Europe.

Original title: Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care and Thrombosis of the European Society of Cardiology. Reference: Martial Hamon et al. EuroIntervention 2013; 8-online publish-ahead-of-print January 2013.

The European Society of Cardiology (ESC) recently published a consensus paper proposing the radial artery as the default access for coronary interventions. 

The evidence emerged from work at the STEMI-RADIAL where radial access in patients admitted for acute coronary syndrome with ST segment elevation was associated with a lower incidence of major bleeding, fewer vascular complications and increased net clinical benefit. The latter is a combination of major cardiovascular events (MACE) and large bleeding was reduced by 58% with radial access (11.0% versus 4.6%, P = 0.0028). Another study that included patients with acute coronary syndrome ST elevation, the RIFLE-STEACS, also showed lower cardiovascular mortality at 30 days compared with patients who received primary angioplasty by femoral access. The RIVAL study and SCAAR register reached a similar conclusion. 

Beyond the evidence of the studies, the operator’s experience remains an important factor. According to the consonance, the hospitals and operators should aim to make more than 50% of procedures by radial access and at least 80 procedures a year in order to achieve and maintain the ability that is technically more demanding. The trans-radial primary angioplasty is recommended only after having experience with stable patients and diagnostic studies. 

Although the above points have seen progress in both operators and materials, they have only made possible a 1.5% conversion to a femoral access approach. The patient’s preference for comfort should not be underestimated as those who have experienced both clearly prefer radial access, mainly because of the possibility of walking quickly. 

Regarding costs, although there has been no work that systematically studied this published yet, common sense suggests that radial access also generates savings for both the hospitals and health authorities generally.

SOLACI.ORG

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

Cardiomyopathies and left atrial enlargement can lead to secondary mitral regurgitation (SMR). This condition is associated with ventricular dysfunction, causing heart failure, hospitalization, and...

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...